A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides ...

The researchers have succeeded in tracing two classic hallmarks of cancer – the evasion of apoptosis (a form of programmed cell death) and the dysregulation of energy metabolism – back to a common ...

The researchers have succeeded in tracing two classic hallmarks of cancer – the evasion of apoptosis (a form of programmed cell death) and the ...

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand ...

Karolinska Development AB ( ($SE:KDEV) ) has provided an update. Karolinska Development’s portfolio company SVF Vaccines has signed a non-binding ...

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand ...

Data from a new mouse model may help advance therapeutic development in celiac disease, including improved TG2 inhibitors and ...

This Q&A with researchers from the Buck Institute and Nautilus Biotechnology reveals how single-molecule proteomics enables unprecedented mapping of tau proteoforms across Alzheimer’s-relevant brain ...

VV169 saw complete clearance of disseminated myeloma tumors within 28 daysAnother dataset highlights Vyriad’s work in improved vector retargeting strategies in a comparative study of three methods for ...

Triple-negative breast cancer (TNBC) is one of the hardest breast cancers to treat because it grows quickly, spreads early and often becomes resistant to therapy. In a new preclinical study, ...